Warning! GuruFocus detected
5 Severe warning signs
with 4QK.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Codexis Inc
NAICS : 541714
SIC : 8731
ISIN : US1920051067
Description
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.23 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | -1.13 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -4.22 | |||||
| Beneish M-Score | -2.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.7 | |||||
| 3-Year EBITDA Growth Rate | -41.1 | |||||
| 3-Year EPS without NRI Growth Rate | -39.1 | |||||
| 3-Year FCF Growth Rate | -18.9 | |||||
| 3-Year Book Growth Rate | -31.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 31.58 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 19.59 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.36 | |||||
| 9-Day RSI | 22.57 | |||||
| 14-Day RSI | 26.36 | |||||
| 3-1 Month Momentum % | -45.84 | |||||
| 6-1 Month Momentum % | -7.83 | |||||
| 12-1 Month Momentum % | -10.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.18 | |||||
| Quick Ratio | 4.1 | |||||
| Cash Ratio | 3.11 | |||||
| Days Inventory | 50.47 | |||||
| Days Sales Outstanding | 52.62 | |||||
| Days Payable | 90.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.9 | |||||
| Shareholder Yield % | -27.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.55 | |||||
| Operating Margin % | -98.33 | |||||
| Net Margin % | -109.99 | |||||
| FCF Margin % | -90.44 | |||||
| ROE % | -88.77 | |||||
| ROA % | -45.63 | |||||
| ROIC % | -91.7 | |||||
| 3-Year ROIIC % | 74.67 | |||||
| ROC (Joel Greenblatt) % | -200.03 | |||||
| ROCE % | -52.81 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.58 | |||||
| PB Ratio | 2.52 | |||||
| Price-to-Tangible-Book | 2.61 | |||||
| EV-to-EBIT | -2.66 | |||||
| EV-to-EBITDA | -2.97 | |||||
| EV-to-Revenue | 2.66 | |||||
| EV-to-Forward-Revenue | 0.64 | |||||
| EV-to-FCF | -3.02 | |||||
| Price-to-GF-Value | 0.76 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Net-Current-Asset-Value | 10.31 | |||||
| Earnings Yield (Greenblatt) % | -37.64 | |||||
| FCF Yield % | -31.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Codexis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 55.176 | ||
| EPS (TTM) (€) | -0.829 | ||
| Beta | 2.31 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 73.71 | ||
| 14-Day RSI | 26.36 | ||
| 14-Day ATR (€) | 0.180337 | ||
| 20-Day SMA (€) | 2.4139 | ||
| 12-1 Month Momentum % | -10.47 | ||
| 52-Week Range (€) | 1.761 - 5.645 | ||
| Shares Outstanding (Mil) | 82.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Codexis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Codexis Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Codexis Inc Frequently Asked Questions
What is Codexis Inc(FRA:4QK)'s stock price today?
The current price of FRA:4QK is €1.86. The 52 week high of FRA:4QK is €5.65 and 52 week low is €1.76.
When is next earnings date of Codexis Inc(FRA:4QK)?
The next earnings date of Codexis Inc(FRA:4QK) is 2025-05-02 Est..
Does Codexis Inc(FRA:4QK) pay dividends? If so, how much?
Codexis Inc(FRA:4QK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers